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Colorectal cancer is the third commonest cancer in both women
and men in developed countries. More than 130 000 new cases are
expected to be diagnosed every year in the US (American Cancer
Society, 1997). Although a genetic predisposition to the disease is
recognized, ample differences in cancer incidence between coun-
tries, over time and among migrants have been interpreted as
suggestive of a prominent role of environmental exposures, espe-
cially diet (Doll and Peto, 1981). A diet high in animal fat or red
meat has been linked to colorectal cancer in ecological studies
(Howell, 1975; Rose et al, 1986) and in a number of analytical
epidemiological studies (Willett, 1989; Willett et al, 1990). The
latter suggest also that a diet low in vegetables and fruit is associ-
ated with increased colorectal cancer risk (Willett, 1989). Various
dietary constituents have been proposed to explain the above asso-
ciations. These include saturated fat (Willett et al, 1990), total calo-
ries (Lyon et al, 1987), polycyclic or heterocyclic amines (Sinha et
al, 1994), dietary fibre (Trock et al, 1990), antioxidant vitamins
(Byers and Perry, 1992), calcium and vitamin D (Bostick, 1993),
but the evidence supporting these hypotheses is incon-clusive.
Various naturally occurring constituents in vegetables and fruits
have been studied for their chemopreventive potential against
colorectal cancer. Among those, folate has recently been the
subject of much research interest. Folate is essential for one-
carbon transfer reactions in the normal synthesis and metabolism
of amino acids, purines, pyrimidines and lipids. It is also a cofactor
in the production of S-adenosylmethionine, the primary methyl
donor in the body (Cooper, 1983). The S-adenosylmethionine-
dependent methylation of specific DNA cytosine bases to form 5-
methylcytosine has been shown to block gene expression, as well
as the abnormal expression of proto-oncogenes (Nyce et al, 1983;
Hoffman, 1984). Increases in the levels of messenger RNA for the
proto-oncogenes c-fos, c-HA-ras, and c-myc have been found to be
correlated with the loss of methylation in the liver of rats on a low
methyl diet (Wainfan and Poirier, 1992). Hypomethylation has
been observed in selected genes (Feinberg and Vogelstein, 1983;
Goelz et al, 1985) as well as in total genomic contents (Feinberg et
al, 1988) in human colonic adenocarcinomas and premalignant
adenoma. In rats, folate deficiency-induced DNA strand breaks
and hypomethylation within the p53 tumor suppressor gene (Kim
et al, 1997). A moderate folate deficiency also enhanced the 
incidence of colonic dysplasia and neoplasia in rats treated with
dimethylhydrazine (Cravo et al, 1992), which was preceded by
alterations in the levels of S-adenosylmethionine and in the
activity of specific methyl transferase enzymes (Halline et al,
1988). Folate supplementation led to a progressive reduction in the
evolution of macroscopic colonic neoplasia from microscopic foci
in a rat model (Kim et al, 1996).
In epidemiological studies, a lower risk of colorectal adenoma
has been observed for individuals with a high folate intake (Benito
et al, 1993; Giovannucci et al, 1993; Tseng et al, 1996; Baron et al,
1998) or high blood folate levels (Bird et al, 1995; Paspatis et al,
1995). Prospective (Giovannucci et al, 1995; Glynn et al, 1996)
and case–control studies of colorectal cancer (Freudenheim et al,
1991; Benito et al, 1991; Ferraroni et al, 1994) have also shown
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folate was inversely associated with the risk of developing colonic
dysplasia or cancer among patients with ulcerative colitis
(Lashner, 1993). Another prospective study found that lower
plasma folate levels were associated with the risk of colorectal
cancer among subjects who had a homozygous mutation in the 
5, 10-methylenetetrahydrofolate reductase (MTHFR) gene, which
is critical for folate metabolism (Ma et al, 1997). Some of the
earlier studies have also suggested that high alcohol or low
protein/methionine intake may modify the effect of folate
(Giovannucci et al, 1993, 1995; Glynn et al, 1996).
Overall evidence in support of a role for folate in the aetiology
of colorectal cancer is still limited and few studies have utilized
biological markers, such as blood folate or homocysteine levels.
MATERIALS AND METHODS
Study population
Study subjects were women who had volunteered to participate 
in the New York University Women’s Health Study. Details
concerning cohort eligibility, procedures of data collection,
follow-up and dietary assessment have been published previously
(Toniolo et al, 1991, 1994, 1995; Kato et al, 1997). Briefly, the
original study population consisted of 15 785 women enrolled in
the study between 1985 and 1991 in New York City (n = 14 275)
or at a collaborating institution in Florida (n = 1510). Women who
in the preceding 6 months had neither used hormonal medications
nor been pregnant were eligible for the study. At enrolment,
written informed consent was obtained; basic demographic,
medical, anthropometric, reproductive and dietary data were
collected through self-administered questionnaires; and 30 ml of
nonfasting peripheral venous blood was drawn.
After the initial examination, the cohort was followed-up
through mailed questionnaires in order to identify incident cases of
cancer diagnosed prior to 1995 and to update some important
epidemiological risk factors. Telephone interviews were
conducted if subjects failed to respond to the mailed questionnaire.
Medical records were obtained from hospitals and reviewed to
confirm pathological diagnoses for self-reported cancer. Record
linkage with state cancer registries in New York, New Jersey and
Connecticut and with the National Death Index supplemented the
active follow-up. The results of capture–recapture analysis (Hook
and Regal, 1995) based on the cases among New York residents
indicated 94% completeness of follow-up.
Nested case–control study
A total of 105 cases of colorectal cancer diagnosed before the end
of 1994 was identified and included in a case–control study nested
within the cohort. This number was very close to the expected
number of cases based on population-based registry data, which
was 100. The subsite distribution of the 105 cancers was as
follows: 25 right colon (caecum, appendix, ascending colon and
hepatic flexure); 8 transverse colon; 38 left colon (splenic flexure,
descending colon and sigmoid colon); 11 rectosigmoid junction;
17 rectum and six unspecified colon. The criteria for control 
selection were identical to those developed for a breast cancer
case–control study in the same cohort and have been described
(Toniolo et al, 1995; Kato et al, 1997). Briefly up to five controls
per case, matched by age, menopausal status at enrolment, date of
enrolment and dates of subsequent blood donations, were
randomly selected from among the cohort members who were
alive and free of colorectal cancer at the time of case diagnosis.
Premenopausal subjects were also matched by day and phase of
the menstrual cycle at enrolment. A total of 523 individually
matched controls were selected. Cases and controls were
contacted by telephone by an interviewer (who was unaware of
their case–control status) to obtain information on colorectal
cancer risk factors in more detail than at the cohort baseline.
Laboratory methods
After blood samples were drawn and centrifuged, the serum was
partitioned into 1-ml aliquots and immediately stored at –80°C
until biochemical assays were performed. Aliquots not previously
thawed were used for this study.
Serum folate was measured using an automated clinical
immunoassay analyser, the Technicon immuno 1® System from
Bayer Corp (Letellier et al, 1996). Serum homocysteine was 
quantified by high performance liquid chromatography (HPLC)
described by Vester and Rasmussen (1991). To ensure comparable
laboratory measurements within matched sets, serum specimens
from a given matched set were always assayed in the same batch,
with the laboratory technician blind as to which were from cases and
which from controls. The intra-assay coefficients of variation for the
standards at the level nearest to the mean concentrations of folate and
homocysteine in our population were 2.8% and 2.6%, respectively.
Folate intake
Dietary folate intake was estimated by using a self-administered,
semi-quantitative diet questionnaire consisting of 70 items of
typical American foods, adapted from a questionnaire developed
and validated at the National Cancer Institute (Block et al, 1986).
Details concerning dietary assessment have been described else-
where (Kato et al, 1997). Study subjects were also asked to
provide information on their use of vitamin/mineral supplements,
including the number of pills consumed, the frequency of use, and
brand names. Dosage was asked only for individual preparations
of vitamins A, C and E. Daily intake of folate supplements was
calculated based on the chemical formulation of the brands, the
number of pills consumed and the frequency of intake. For
subjects who could not specify the name of their brand, the mean
dose of all other brands used by the study subjects was applied.
Statistical analysis
The variables which were tested in this study as predictors of the
risk of colorectal cancer are serum folate, serum homocysteine and
total folate intake (diet + supplements). In order to reduce depar-
tures from the normal distribution, the measurements of serum
folate, homocysteine and total folate intake were log-transformed.
In univariate analyses, the measurements for individual cases were
compared with the mean levels for their matched controls using a
paired t-test. Odds ratios (OR) for colorectal cancer by quartiles of
these measurements and 95% confidence intervals (CI) were
computed from conditional logistic regression models (Breslow
and Day, 1990). Cut-off points for quartiles were obtained from
the combined distribution of cases and controls included in 
particular analyses. Tests for linear trend in the logit of risk were
calculated from conditional logistic regression models using
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following subsites: proximal colon (right + transverse colon),
distal colon (left colon + rectosigmoid junction) and rectum.
Several potential confounders other than the matching variables
were first screened individually in the model. These included
demographic variables (education, race, religion), physical activity
levels at two time points (5 years before diagnosis and in their
early 30s), history of regular aspirin use, family history of
colorectal cancer, alcohol consumption (total, beer, wine and
liquor), cigarette smoking, history of occult blood testing, total
calorie intake, intakes of calorie-adjusted macronutrients (carbo-
hydrate, protein and fat) and of dietary fibre, total intake of vita-
mins A, C and E, height and Quetelet index (weight in kilograms
divided by height in m2). Variables showing associations with the
risk of colorectal cancer at P < 0.10 were further tested in forward
stepwise-conditional regression models. The final model consisted
of those variables showing a significant association with the risk of
colorectal cancer at P < 0.05 level in the stepwise multiple regres-
sion model, i.e. beer intake (0, <3 or ³ 3 cans per week), sport
activities in their early 30s (0, <3 or ³ 3 h per week), history of
occult blood testing, and family history of colorectal cancer among
first-degree relatives. Reported adjusted odds ratios were
computed using this model.
RESULTS
Selected characteristics of the cases and controls are presented in
Table 1. The cases and controls were similar in age, race and reli-
gion. They had similar levels of total calorie and alcohol consump-
tion and similar body mass induces. Controls tended to be more
educated, and more likely to be taking vitamin/mineral supple-
ments and aspirin.
In univariate analyses (Table 2), the cases had significantly lower
serum folate and higher serum homocysteine levels than controls.
The difference was more pronounced for folate (P < 0.001) than
homocysteine (P = 0.044). When analysed by subsite, the differ-
ences were greatest for the distal colon, followed by the proximal
colon and rectum. To assess whether the presence of preclinical
cancer may have affected the levels of serum markers, we exam-
ined whether serum folate and homocysteine concentrations among
the cases were associated with the length of time between the
drawing of blood and diagnosis. However, there were no apparent
increasing or decreasing trends in the concentration of either folate
or homocysteine as the date when the blood sample was obtained
approached the date of diagnosis (data not shown).
The odds ratios for colorectal cancer in uni- and multivariate
analyses are shown in Table 3. The adjustment for potential
confounders made no substantial change in the ORs associated
with serum folate and homocysteine. Among those in the highest
quartile of serum folate (³ 31.1 nmol l–1), the risk of developing
colorectal cancer was about half that of those in the lowest quartile
(≤12.2 nmol l–1). The risk of colorectal cancer decreased with
increasing serum folate levels (P-value for trend = 0.04). When the
seven cases who were diagnosed within 1 year of their blood
sample were excluded, the odds ratio did not change (0.50, 
95% CI: 0.26–0.96, P-value for trend = 0.04). For homocysteine,
subjects in the highest quartile (> 12.2 mmol l–1) had a 70%
increase in risk of colorectal cancer compared with those in the
lowest quartile (≤ 7.9 mmol l–1) (P = 0.09). The associations were
strongest for distal colon, followed by proximal colon and rectum
(data not shown). The inverse association between serum folate
and colorectal cancer risk was observed for both vitamin/mineral
supplement users and nonusers. The odds ratios for the highest
compared to the lowest quartile of serum folate levels were 0.54
(95% CI: 0.22–1.35) among supplement users (62 sets) and 0.18
(95% CI: 0.02–1.73) among nonusers (31 sets), using separate
quartile levels for users and nonusers.
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Table 1 Characteristics of study subjects
Mean ± SD or percent
Characteristics Cases Controls
No. of subjects 105 523
Age at study entry (years) 61.6 ± 7.5 61.6 ± 7.4
Age at diagnosis (years) 66.2 ± 8.6 –
White 85.4% 86.2%
Jewish 48.3% 51.0%
Graduate school 15.7% 21.8%
Current smoker 7.9% 14.4%
Quetelet indexa 26.1 ± 4.9 25.6 ± 4.6
Alcohol intake (drinks/week) 1.89 ± 4.7 1.89 ± 6.4
Calorie intake (kcal/day) 1500 ± 581 1490 ± 651
Vitamin/mineral supplement use 60.2% 71.3%
Regular aspirin use 6.3% 14.4%
aWeight/height (kg m–2).
Table 2 Differences in serum levels of folate and homocysteine and total intake of folate between colorectal cases and matched controls
All sites Proximal colon Distal colon Rectum
Variables (105 sets) (33 sets) (49 sets) (17 sets)
Serum folate (nmol l–1)
Geometric mean of cases 17.08 17.58 15.96 18.43
Mean difference (case–controls) –5.36 –4.31 –7.59 –2.10
P-value <0.001 0.203 0.001 0.662
Serum homocysteine (mmol l–1)
Geometric mean of cases 10.35 11.30 10.02 9.62
Mean difference (case–controls) 0.67 0.72 0.89 0.15
P-value 0.044 0.352 0.022 0.805
Total folate intake (mg day–1)
Geometric mean of cases 354.2 404.6 309.8 385.3
Mean difference (case–controls) –21.9 51.8 –70.5 –24.6
P-value 0.476 0.413 0.076 0.762In analyses of folate intake from diet and supplements, the overall
differences between cases and controls were small, but the cases with
distal colon cancer tended to consume less folate than their matched
controls (P = 0.08) (Table 2). Correspondingly, the univariate OR for
the highest quartile of total folate intake (³ 626 mg day–1) compared
with the lowest (≤ 224 mg day–1) was 0.32 (95% CI: 0.11–0.93,
P-value for trend = 0.01) for distal colon cancer. Adjusting for
confounders weakened the OR to 0.43 (95% CI: 0.14–1.39, P-value
for trend = 0.18) (data not shown).
In our study population, supplemental folate represented 39% of
the total folate intake. We therefore examined whether the use of
vitamin/mineral supplements was associated with colorectal
cancer risk. The OR associated with any vitamin/mineral supple-
ment use was 0.62 (95% CI: 0.40–0.96) in univariate and 0.67
(95% CI: 0.42–1.06) in multivariate analyses.
There was no statistical interaction between alcohol consump-
tion and serum folate levels. However, participants who were in
the lower half of serum folate and the upper half of total alcohol
consumption had a risk of developing colorectal cancer almost
twice as high as those who were in the upper half of serum folate
and the lower half of total alcohol consumption (OR = 1.99, 95%
CI: 0.92–4.29). No such increase in risk was observed for the
combination of low serum folate and low protein intake.
The Spearman rank correlation coefficients among the three
folate indices were 0.52 between total folate intake and serum
folate, –0.36 between serum folate and homocysteine and – 0.26
between total folate intake and serum homocysteine.
DISCUSSION
Despite uncertainties regarding the underlying biological mecha-
nisms, several lines of laboratory evidence suggest that folate may
be protective against colorectal cancer. To our knowledge, the
present epidemiological study is the first to assess prospectively
the relationship between biological markers for folate status and
colorectal cancer risk among women. The blood specimens used
for this analysis were taken between 2.4 months and 9.1 years
before the subjects were diagnosed with colorectal cancer. The
study found a progressive decrease in risk of colorectal cancer
with increasing serum folate levels and with decreasing homo
cysteine levels.
Two other prospective studies have assessed the relationship
between serum/plasma folate levels and colorectal cancer risk in
selected male populations, Finnish smokers and US physicians
(Glynn et al, 1996; Ma et al, 1997). While the study in Finnish
smokers found no association (Glynn et al, 1996), the US physi-
cians’ study found a marginally significant increased risk in men
with a severe depletion in plasma folate levels (Ma et al, 1997).
Subjects in both studies had taken some intervention materials,
such as antioxidant vitamins or aspirin, so that the effect of folate
may have been confounded by such treatments. There have been
some small earlier cross-sectional studies of subjects undergoing
colonoscopic examinations which looked at biological markers for
folate status. Two such studies found an inverse association of
colorectal adenoma or dysplasia with red cell folate levels for both
genders combined (Lashner, 1993; Paspatis et al, 1995), while
another showed an inverse association with plasma folate in men,
but not in women (Bird et al, 1995). These studies, however,
cannot distinguish between the causes and consequences of a
disease. Other such studies based on either total or dietary folate
intake have yielded mixed results (Benito et al, 1991, 1993;
Freudenheim et al, 1991; Giovannucci et al, 1993; Ferraroni et al,
1994; Tseng et al, 1996; Baron et al, 1998). Overall, the decrease
in risk of colorectal cancer for subjects in the highest quartile or
quintile levels of the folate measurements ranged from 75% to
35%. These reductions in risk are comparable with the odds ratio
of 0.52 observed in the present study.
Previous studies have also suggested interactions of folate
intake with alcohol and with protein/methionine. Ethanol and its
metabolites can lower blood folate levels through several different
mechanisms, such as promoting catabolism, inhibiting absorption
and increasing excretion (Eichner and Hillman, 1971; Romero et
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Table 3 Univariate and multivariate odds ratios for colorectal cancer according to quartile levels of serum folate and homocysteine and total folate intake
Univariate Multivariatea
Variables OR 95% CI OR 95% CI
Serum folate (nmol l–1)
≤ 12.23 1.00 — 1.00 —
12.24–19.25 0.66 0.38–1.17 0.67 0.37–1.23
19.26–31.03 0.60 0.34–1.06 0.66 0.36–1.21
³31.04 0.46 0.25–0.85 0.52 0.27–0.97
P for trend 0.01 0.04
Serum homocysteine (mmol l–1)
≤ 7.9 1.00 — 1.00 —
7.91–9.90 1.04 0.53–2.07 1.06 0.52–2.17
9.91–12.2 1.66 0.84–3.28 1.51 0.74–3.08
³ 12.21 1.73 0.86–3.45 1.72 0.83–3.57
P for trend 0.07 0.09
Total folate intake (mg day–1)
≤224 1.00 1.00
225–413 0.78 0.42–1.44 0.92 0.48–1.74
414–625 0.70 0.38–1.29 0.87 0.45–1.70
³ 626 0.67 0.36–1.23 0.88 0.46–1.69
P for trend 0.17 0.67
aAdjusted for family history of colorectal cancer, beer intake, prior occult blood testing and number of hours spent in sport activities in their early 30s.al, 1981; Shaw et al, 1989). Methionine, an amino acid derived
from protein, and folate are both essential for the production of 
S-adenosylmethionine (Cooper et al, 1983). In the two recent
prospective studies, a significant increase in risk of colorectal
cancer associated with lower folate intake was only observed in
the combination with higher alcohol and lower methionine/protein
intake (Giovannucci et al, 1995; Glynn et al, 1996). In our study,
despite the lack of association with total alcohol intake, there was
a marginal indication that the combination of higher alcohol and
lower serum folate levels may increase the risk of colorectal
cancer in women. However, it should be noted that the mean
alcohol intake in the New Women’s Health Study cohort was rela-
tively low compared with that in other cohorts, so that it may not
be the most appropriate for a study of the interaction with alcohol.
Three measurements were used to assess folate status in the
present study and while an association with colorectal cancer risk
was found with the two serum markers, there was almost no 
association with total folate intake. These discrepancies may be
explained in several different ways: (1) the dose from internal
exposure (blood folate) is not perfectly correlated with that from
external exposure (intake) because of differences in absorption and
metabolism. The Spearman rank correlation between total intake
and serum levels in our study subjects was 0.52. Some recent
studies reported that certain mutations in the gene of a folate-
related enzyme, MTHFR, which led to reduced blood folate levels,
were associated with the risk of colorectal cancer (Chen et al,
1996; Ma et al, 1997). (2) Measurement errors in total folate intake
may have reduced differences between cases and controls.
Although our dietary questionnaire consisting of 70 food items
was adapted from a questionnaire designed to capture over 90% of
17 major nutrient intakes (Block et al, 1986), it was less compre-
hensive than those being used more recently (Benito et al, 1991,
1993; Giovannucci et al, 1993, 1995; Bird et al, 1995; Glynn et al,
1996; Tseng et al, 1996; Baron et al, 1998). However, the esti-
mated dietary and total folate intakes were comparable with, or
higher than, those based on more comprehensive questionnaires
(Benito et al, 1991, 1993; Giovannucci et al, 1993, 1995; Bird et
al, 1995; Glynn et al, 1996; Tseng et al, 1996; Baron et al, 1998).
In a reproducibility study of our dietary questionnaire, in which it
was administered to 267 cohort members after an interval of 2–3
months, the Spearman rank correlation for dietary folate was 0.66.
Because serum folate tends to reflect the short-term balance of
folate, red-cell folate (which is an indicator of tissue levels) may
be a more appropriate index of chronic folate deficiency. To
compensate for the lack of red-cell specimens in our study, we
measured serum homocysteine, which has been proposed as a
sensitive indicator of functional folate deficiency that is distin-
guishable from low serum folate concentrations following short-
term decreases in dietary intake (Kang et al, 1987; Stabler et al,
1988; Ubbink et al, 1993; Jacob et al, 1994; O’Keefe et al, 1995).
Our data show that the variability of serum homocysteine in the
population was much narrower than that of folate, suggesting that
homocysteine levels are more tightly regulated by metabolism.
Recent studies show that factors other than folate, such as sex
steroids, also affect serum homocysteine levels (Giltay et al,
1998). Thus, homocysteine seems to be a less sensitive indicator of
mean folate intake than is direct measurement of serum folate.
Several limitations in the present study arise from the fact that
the original study was designed for breast cancer. For example,
because of the relatively small number of colorectal cancer cases,
our study had limited statistical power for analyses by subsite  of
risk factors that have been reported by other authors Broeders et al,
1996; Lund, 1996; (Thune and Wurzelmann et al, 1996). Secondly,
epidemiological variables collected at baseline were mostly poten-
tial risk factors for breast cancer. Those specific to colorectal
cancer were collected retrospectively on a case–control basis by
telephone interview and biases in the measurement of confounding
factors, which are typically seen in case–control studies, may have
affected risk estimates. Third, because the follow-up was relatively
short (average 4.7 years), some cases may have had preclinical
cancer when their blood sample was taken and this may have influ-
enced serum folate and homocysteine levels. However, the exclu-
sion of cases diagnosed within 1 year of blood donation did not
alter the results. Finally, as our study subjects were participants in
breast cancer screening, they were likely to be more health
conscious (Kato et al, 1986, 1987) and more homogeneous than
the general population, as was subsequently shown by the high
prevalence of vitamin/mineral supplement use. Consequently, the
number of subjects whose serum levels were indicative of folate
deficiency (< 6.8 nmol l–1) was too small (4.5%) for analysis of the
effect of very low levels. Also, because the majority of our study
subjects was taking multi-vitamin pills, it is possible that serum
folate serves as a marker for other vitamins in the blood. For the
above reasons and because our cohort is self-selected and consists
of a middle-class and largely Caucasian population, caution needs
to be exercised in generalizing the results.
In summary, the results of the present study support the hypoth-
esis that folate may be protective against colorectal cancer.
However, due to the limitations of observational epidemiological
studies, the potentially protective effects of folate against
colorectal cancer need to be addressed in clinical trials.
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